FDA 483 - Jiangsu Caina Medical Co., Ltd - March 23, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
The FDA inspection of JIANGSU CAINA MEDICAL CO., LTD in Jiangyin, China, revealed significant quality system deficiencies for medical devices intended for the US market. The firm failed to submit required MDR reports, lacked adequate corrective and preventive action procedures, and had insufficient risk analysis. Additionally, issues included poor control of nonconforming products, improper identification of product acceptance status, and inadequate device history records, compounded by personnel unfamiliar with US FDA regulations.
ID · a44b4649-a9a6-4c5b-a4d6-b45fd0534c32